
Saibal Kar MD
Interventional Cardiology
Associate Professor, Medicine, UCLA School of Medicine
Join to View Full Profile
227 W Janss RdSte 340Thousand Oaks, CA 91360
Phone+1 805-852-9100
Fax+1 805-852-9101
Dr. Kar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saibal Kar is a cardiologist in Thousand Oaks, CA and is affiliated with Los Robles Hospital and Medical Center. He received his medical degree from NRS Medical College Calcutta and has been in practice 29 years. He specializes in interventional cardiology and is experienced in aortic stenosis, mitral valve disease, mitral stenosis, mitral regurgitation, and tricuspid regurgitation.
Education & Training
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1998 - 2001
- UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1996 - 1998
- NRS Medical College CalcuttaClass of 1988
Certifications & Licensure
- CA State Medical License 1997 - 2025
- TX State Medical License 2017 - 2017
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
- Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.Saibal Kar, Raj R Makkar, Brian K Whisenant, Nadira Hamid, Hursh Naik
Circulation. 2025-03-30 - 2 citationsEvaluating Mitral TEER in the Management of Moderate Secondary Mitral Regurgitation Among Heart Failure Patients.Anita W Asgar, Gilbert H L Tang, Jason H Rogers, Wolfgang Rottbauer, M Andrew Morse
JACC. Heart Failure. 2025-02-01 - 9 citationsTricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort.Gilbert H L Tang, Rebecca T Hahn, Brian K Whisenant, Nadira Hamid, Hursh Naik
Journal of the American College of Cardiology. 2025-01-28
Journal Articles
- Structural 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position from the COMPASSION Multicenter Clinical TrialGregory A Fleming, Girish S Shirali, Mark A Fogel, Julie Vincent, Vasilis C Babaliaros, Dennis W Kim, Evan M Zahn, John F Rhodes, Saibal Kar, Aimee K Armstrong, ScienceDirect
- Transcatheter Mitral-Valve Repair in Patients with Heart FailureJoAnn Lindenfeld, Saibal Kar, Michael J Mack, Samir R Kapadia, Gregg W Stone, Ian J Sarembock, William T Abraham, Andreas Brieke, David J Cohen, Steven O Marx, Brian W..., The New England Journal of Medicine
Lectures
- LAA Occlusion Complications I: If It Can Happen, It Will (With Case Examples)CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Watchman I: Device Evolution, Patient Selection, and Tips and TricksCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- MitraClip Tricuspid… Growing Experience – Technology and Clinical Updates (Triluminate I & II)CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
- Join now to see all
Press Mentions
- TriClip's Tricuspid TEER Cuts Heart Failure HospitalizationsApril 1st, 2025
- HMN 2025: How Minimally Invasive Valve Restore Reduces Coronary Heart Failure Hospitalizations in Sufferers with Extreme Tricuspid RegurgitationApril 1st, 2025
- By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATEMarch 31st, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: